Oral and intestinal mucositis - causes and possible treatments.
about
Interventions for preventing oral mucositis for patients with cancer receiving treatmentInterventions for preventing oral mucositis for patients with cancer receiving treatmentInterventions for preventing oral mucositis for patients with cancer receiving treatmentThe molecular immunology of mucositis: implications for evidence-based research in alternative and complementary palliative treatments.Olmesartan decreased levels of IL-1β and TNF-α, down-regulated MMP-2, MMP-9, COX-2, RANK/RANKL and up-regulated SOCs-1 in an intestinal mucositis modelApolipoprotein E COG 133 mimetic peptide improves 5-fluorouracil-induced intestinal mucositis.Irinotecan-Induced Gastrointestinal Dysfunction Is Associated with Enteric Neuropathy, but Increased Numbers of Cholinergic Myenteric Neurons.Activation of p38-MAPK by CXCL4/CXCR3 axis contributes to p53-dependent intestinal apoptosis initiated by 5-fluorouracilRole of inducible nitric oxide synthase pathway on methotrexate-induced intestinal mucositis in rodents.Efficacy of CR3294, a new benzamidine derivative, in the prevention of 5-fluorouracil-induced gastrointestinal mucositis and diarrhea in miceSaireito (TJ-114), a Japanese traditional herbal medicine, reduces 5-fluorouracil-induced intestinal mucositis in mice by inhibiting cytokine-mediated apoptosis in intestinal crypt cells.Chemotherapy-induced and/or radiation therapy-induced oral mucositis--complicating the treatment of cancer.Affinity based multilayered polymeric self-assemblies for oral wound applicationsLactobacillus plantarum NCU116 attenuates cyclophosphamide-induced intestinal mucosal injury, metabolism and intestinal microbiota disorders in mice.Radiation-Induced Esophagitis is Mitigated by Soy Isoflavones.Emerging approaches for prophylaxis and management of oropharyngeal mucositis in cancer therapy.Tyrphostins reduce chemotherapy-induced intestinal injury in mice: assessment by a biochemical assay.5-HT₃ receptor antagonists ameliorate 5-fluorouracil-induced intestinal mucositis by suppression of apoptosis in murine intestinal crypt cellsA randomised double-blind placebo-controlled phase II study of AGI004 for control of chemotherapy-induced diarrhoea.p38 MAPK signaling in oral-related diseases.Grape seed extract dose-responsively decreases disease severity in a rat model of mucositis; concomitantly enhancing chemotherapeutic effectiveness in colon cancer cells.Oral Administration of Surface-Deacetylated Chitin Nanofibers and Chitosan Inhibit 5-Fluorouracil-Induced Intestinal Mucositis in Mice.Alanyl-glutamine and glutamine supplementation improves 5-fluorouracil-induced intestinal epithelium damage in vitroEvidence supporting the use of probiotics for the prevention and treatment of chemotherapy-induced intestinal mucositis.Interaction between host cells and microbes in chemotherapy-induced mucositis.Radiation-induced oral mucositis and periodontitis - proposal for an inter-relationship.The Role of Grape Seed Extract in the Treatment of Chemo/Radiotherapy Induced Toxicity: A Systematic Review of Preclinical Studies.Apoptosis, Dysbiosis and Expression of Inflammatory Cytokines are Sequential Events in the Development of 5-Fluorouracil-Induced Intestinal Mucositis in Mice.Irinotecan- and 5-fluorouracil-induced intestinal mucositis: insights into pathogenesis and therapeutic perspectives.Oral Nucleotides Only Minimally Improve 5-Fluorouracil-Induced Mucositis in Rats.Escherichia coli Nissle 1917-derived factors reduce cell death and late apoptosis and increase transepithelial electrical resistance in a model of 5-fluorouracil-induced intestinal epithelial cell damage.Sensing danger: toll-like receptors and outcome in allogeneic hematopoietic stem cell transplantation.Intestinal mucosal dysfunction and infection during remission-induction therapy for acute myeloid leukaemia.Hydroalcoholic extract of Carum carvi L. in oral mucositis: a clinical trial in male golden hamsters.Dietary squid ink polysaccharide induces goblet cells to protect small intestine from chemotherapy induced injury.Regulatory role of Lactobacillus acidophilus on inflammation and gastric dysmotility in intestinal mucositis induced by 5-fluorouracil in mice.Oral Mucositis in Pediatric Acute Lymphoblastic Leukemia Patients: Evaluation of Microbiological and Hematological Factors.Alterations in epithelial and mesenchymal intestinal gene expression during doxorubicin-induced mucositis in mice.Altered systemic bioavailability and organ distribution of azathioprine in methotrexate-induced intestinal mucositis in rats.The effect of olive leaf extract in decreasing the expression of two pro-inflammatory cytokines in patients receiving chemotherapy for cancer. A randomized clinical trial.
P2860
Q24235217-7D6E5EA9-1B41-4923-9C4F-BEE076F3EA42Q24235482-C110398E-FFA0-4C31-A499-581BEA5070E5Q24243046-4C6FE8E4-82F9-4B7D-8169-144CE97EAB07Q24812445-AB9C5E5E-7673-4052-8938-83630879B780Q28542802-D4699D21-F033-44F1-8FC5-37411F7D6813Q30425943-31E02CD0-8C9F-4390-8CC3-0D0654D41470Q33774788-730730C8-C082-4A6B-99FE-8AC355BCC740Q33990012-1F26F334-A647-46D8-92E8-F684F8D6F8EAQ33994068-C9999DFE-D9FE-4375-A472-711BA654598FQ34080590-2480CF38-51CC-46F7-A58B-D5B23BF9BE4CQ34856264-DA9A8804-7665-42B8-9AFF-61A8D7440CDFQ34928237-9197584E-6CD7-4447-BF2C-8D26C5B2A288Q35013217-2AF0AC12-AFC6-4A83-8F5F-D0D66A3B8376Q35932477-AE556B53-3926-4B02-9AC4-29624C98A123Q36196702-6A95ED53-E3A2-4D18-8364-17517B49812BQ36458432-128EE57D-BA93-4CB9-9B47-585C2AFF8790Q36616082-987FC78B-F58E-4BBA-98BC-0B7479118625Q36681766-5E16A62D-CFA1-4D19-B26C-E385A64F1EECQ36746734-A53E562B-C14C-4436-B778-C5D1E98E610FQ36919722-31BE348F-2F74-4018-BCC6-B0852F33A565Q37499330-287C44D6-17CA-4BDE-9463-EE00E5049511Q37690712-6CD81E60-BE70-4A4B-BB66-7A5293CFE5DBQ37730914-DD97EE2A-0DB2-4898-AEB1-77659ECDFC69Q37851431-8042A7C6-CFC9-4705-B093-6BAE4EBAA905Q38102867-57FA5D50-34BB-4EE9-840A-C577D27E1A5CQ38154627-E0A4B6AA-5B4D-4F84-8784-BD18FA275001Q38424055-A50D1DD6-EA5A-4A25-9371-B6AA7907C2E1Q38856557-E300FB8B-03A4-462E-BD2F-B76418E5C321Q38945299-4CC4A2B0-963A-4137-B681-14BCBACDDA44Q38973185-CB2834BB-FE70-4592-A3CC-0535A66CA3EDQ39022027-95726ABC-3817-49C0-99F9-8F814DEEF54EQ39035928-2EEBDD26-CF46-4597-B3FE-7073A53DBF0EQ40273088-5A52D91E-4C16-4418-BF17-1E4DED43C820Q41312854-4BFEB279-D643-4B82-A8A4-F674EAD5C1C9Q41490537-95C507EE-AE22-4A58-A824-C55BED180C51Q41603883-A0916D73-6066-459B-A09B-0C6BCC9AF013Q41659960-C77F6A78-7BC6-4535-BE8E-611CF9ECCD3BQ41903928-A5725E86-CD13-4B1D-989B-6B0F1E22ABC5Q42736254-35619E9B-269E-4BBC-994F-D3BA5A6689A7Q42778757-B11FDE06-5D61-40C5-8DCE-29CB3C63EB0A
P2860
Oral and intestinal mucositis - causes and possible treatments.
description
2003 nî lūn-bûn
@nan
2003 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Oral and intestinal mucositis - causes and possible treatments.
@ast
Oral and intestinal mucositis - causes and possible treatments.
@en
type
label
Oral and intestinal mucositis - causes and possible treatments.
@ast
Oral and intestinal mucositis - causes and possible treatments.
@en
prefLabel
Oral and intestinal mucositis - causes and possible treatments.
@ast
Oral and intestinal mucositis - causes and possible treatments.
@en
P2860
P1476
Oral and intestinal mucositis - causes and possible treatments.
@en
P2093
P2860
P304
P356
10.1046/J.1365-2036.2003.01784.X
P407
P577
2003-11-01T00:00:00Z